These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 264506)

  • 1. Metastatic prostate carcinoma to the mandible: report of case.
    Mesa ML
    J Oral Surg; 1977 Feb; 35(2):133-5. PubMed ID: 264506
    [No Abstract]   [Full Text] [Related]  

  • 2. [The diagnostic value of serum acid phosphatases in carcinoma of the prostate (author's transl)].
    Braun JS; Habig H; Crüsemann D
    Urologe A; 1974 Sep; 13(5):236-41. PubMed ID: 4138057
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contribution on the clinical aspects of prostatic carcinoma].
    Sladczyk E
    Z Arztl Fortbild (Jena); 1967 Jul; 61(13):657-60. PubMed ID: 5598256
    [No Abstract]   [Full Text] [Related]  

  • 4. [Immunochemical measurement of prostatic acid phosphatase in carcinoma of the prostate].
    Cooper EH; Bauer HW; Dati F
    Ric Clin Lab; 1984; 14 Suppl 2():39-55. PubMed ID: 6085183
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metastatic tumors of the mandible].
    Antognini F; Cavina C; Giuliani R; Magagnoli PP
    Minerva Stomatol; 1977; 26(4):185-207. PubMed ID: 275536
    [No Abstract]   [Full Text] [Related]  

  • 6. [Carcinoma of the prostate metastasized to mandible simulating primary parotid tumor].
    Angulo JC; López JI; Ruiz de Galarreta JC; Larrinaga JR; Flores N
    Arch Esp Urol; 1993 Mar; 46(2):143-4. PubMed ID: 8498856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The ORL area as the seat of metastases. A case report of mandibular metastasis of adenocarcinoma of the prostate gland].
    Mompó Romero L; Faubel Serra M; Pons Rocher F; Guallart Doménech F
    An Otorrinolaringol Ibero Am; 1994; 21(3):223-30. PubMed ID: 8037364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Occult carcinoma of the prostate.
    El-Morsi AR
    J Egypt Med Assoc; 1974; 57(7-8):373-7. PubMed ID: 4452775
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II evaluation of weekly cisplatin in metastatic hormone-resistant prostate cancer: a Southeastern Cancer Study Group Trial.
    Moore MR; Troner MB; DeSimone P; Birch R; Irwin L
    Cancer Treat Rep; 1986 Apr; 70(4):541-2. PubMed ID: 3698053
    [No Abstract]   [Full Text] [Related]  

  • 10. Prostatic carcinoma metastatic to the mandible: report of case.
    Snyder SR; Merkow LP; White NS
    J Oral Surg; 1971 Mar; 29(3):205-7. PubMed ID: 5278871
    [No Abstract]   [Full Text] [Related]  

  • 11. The treatment of advanced prostatic carcinoma with medroxyprogesterone.
    Rafla S; Johnson R
    Curr Ther Res Clin Exp; 1974 Apr; 16(4):261-7. PubMed ID: 4208339
    [No Abstract]   [Full Text] [Related]  

  • 12. Acid phosphatase, alkaline phosphatase and prostate-specific antigen--usefulness in the diagnosis of metastatic disease and follow-up.
    Bauer HW
    Prog Clin Biol Res; 1988; 269():33-42. PubMed ID: 2455908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical aspects of prostatic carcinoma.
    Foo KT; Tan EC; Tung KH; Lee YS
    Singapore Med J; 1982 Oct; 23(5):269-72. PubMed ID: 7157007
    [No Abstract]   [Full Text] [Related]  

  • 14. [Late results of treatment of prostatic cancer].
    Hanschke HJ; König K; Caspar W
    Dtsch Med Wochenschr; 1968 Nov; 93(47):2271-4. PubMed ID: 5686345
    [No Abstract]   [Full Text] [Related]  

  • 15. [The prognostic significance of alkaline and acid phosphatase levels in the hormonal treatment of patients with prostatic carcinoma].
    Mulders PF; Debruyne FM
    Ned Tijdschr Geneeskd; 1987 Aug; 131(32):1399-402. PubMed ID: 3658014
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of advanced metastasizing carcinoma of the prostate with estracyt (author's transl)].
    Rambausek M; Lutherer S; Terhorst B
    Urologe A; 1981 Jul; 20(4):223-7. PubMed ID: 7196632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum acid phosphatase levels in untreated carcinoma patients.
    Ho E; Mehan DJ
    Mo Med; 1975 Jun; 72(6):289-90. PubMed ID: 1143260
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening for adenocarcinoma of the prostate.
    Miles BJ
    Henry Ford Hosp Med J; 1989; 37(1):5-7. PubMed ID: 2475458
    [No Abstract]   [Full Text] [Related]  

  • 19. [The clinical and prognostic value of inversion of the PSA/PAP ratio in prostatic cancer].
    Morote Robles J; Lorente JA; Reig C; López Pacios MA; de Torres JA; Soler Roselló A
    Actas Urol Esp; 1994 May; 18(5):559-61. PubMed ID: 7521563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of survival of metastatic prostate cancer based on early serial measurements of prostate specific antigen and alkaline phosphatase.
    Robinson D; Sandblom G; Johansson R; Garmo H; Stattin P; Mommsen S; Varenhorst E;
    J Urol; 2008 Jan; 179(1):117-22; discussion 122-3. PubMed ID: 17997442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.